COVID-19 Coverage and Billing - Public Health Emergency Set to End
As previously announced, our COVID-19 billing rules and guidelines will remain in effect through the Public Health Emergency (PHE), which expired on Thursday, May 11, 2023. As a result, some of the rules and guidelines put into place in response to the PHE will now be reversed. This means that member cost share and benefit plan rules may apply to services that were previously covered at 100% during the PHE.
Commercial and Medicare Advantage Post PHE Vaccination and Testing Coverage:
If you have questions about your coverage and COVID-19 and telehealth related costs, please call member services using the numbers below:
Commercial: 866.895.5828
Medicare Advantage: 800.455.9776
Latest on COVID-19: Testing & Vaccines
IU Health has a COVID-19 Resource Center with the latest information on testing, vaccines and more at iuhealth.org/covid19.
COVID-19 Coverage and Billing - Public Health Emergency Set to End
As previously announced, our COVID-19 billing rules and guidelines will remain in effect through the Public Health Emergency (PHE), which expired on Thursday, May 11, 2023. As a result, some of the rules and guidelines put into place in response to the PHE will now be reversed. This means that member cost share and benefit plan rules may apply to services that were previously covered at 100% during the PHE.
Commercial and Medicare Advantage Post PHE Vaccination and Testing Coverage:
If you have questions about your coverage and COVID-19 and telehealth related costs, please call member services using the numbers below:
Commercial: 866.895.5828
Medicare Advantage: 800.455.9776
Latest on COVID-19: Testing & Vaccines
IU Health has a COVID-19 Resource Center with the latest information on testing, vaccines and more at iuhealth.org/covid19.
Thank you for visiting the IU Health Plans website, we value your opinion on how we can improve your online experience. After you complete your visit, would you be willing to answer a few questions to help us improve our website? Please complete this survey after you have completed your online session.
Yes Maybe Later NeverIn the interest of our members’ health and safety, IU Health Plans monitors alerts from the Food and Drug Administration (FDA) regarding prescription drug recalls and withdrawals. Drugs may be recalled by the FDA or withdrawn from the market by a manufacturer for a variety of reasons including safety and efficacy. IU Health Plans identifies and notifies members that may be potentially impacted when a prescription drug is recalled or withdrawn. In addition to these notifications, updates will be provided on this webpage for easy access for our members and providers.
The FDA classifies recalls according to the potential consequences the drug may cause. The FDA defines these classifications as follows:
Class I: Dangerous or defective products (including drugs) that predictably could cause serious health problems or death. Examples include: a label mix-up on a lifesaving drug
Class II: Products (including drugs) that might cause a temporary health problem, or pose only a slight threat of a serious nature. Example: a drug that is under-strength but that is not used to treat life-threatening situations.
A drug manufacturer may call a voluntary market withdrawal to remove or correct a marketed drug that the FDA may consider to be in violation of FDA laws.
If you receive a notice that your medications may be impacted by a drug recall please act upon the notice and follow up with your prescriber and/or pharmacy as instructed. If you have additional questions about your prescription drug benefits please contact us.
Multiple Akorn Inc. Products 01.14.23
Diltiazem Hydrochloride 08.04.22
Orphenadrine Citrate ER 03.23.22
Accuretic and quinapril 03.21.22
Lidocaine 2.5 % and Prilocaine 2.5 % Cream 04.28.22
Glenmark Pharmaceuticals 04.25.22
Teligent Pharmaceuticals 03.21.22
Similac®, Alimentum®, and EleCare® 02.18.22 & 02.28.22
